Ovzon AB (publ) (OVZON.ST)
SEK 16.62
(26.68%)
SEK 16.62
(26.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 290 Million | 356.99 Million | 191.37 Million | 160.47 Million | 231.64 Million | 207.88 Million |
| Cost of Revenue | 205 Million | 232.29 Million | 166.77 Million | 99.01 Million | 114.21 Million | 117.21 Million |
| Gross Profit | 85 Million | 124.69 Million | 24.6 Million | 61.46 Million | 117.42 Million | 90.67 Million |
| Operating Expenses | 180 Million | 205.75 Million | 137.98 Million | 109.74 Million | 106 Million | 108.2 Million |
| Selling, General and Administrative Expenses | - | 105.26 Million | 58.86 Million | 48.36 Million | 44.62 Million | 74.64 Million |
| Research and Development Expenses | - | - | 446 Thousand | 2.14 Million | 3.68 Million | 5.4 Million |
| Other Expenses | 180 Million | 100.49 Million | 79.11 Million | 61.37 Million | 61.38 Million | 33.56 Million |
| Cost and Expenses | 385 Million | 438.05 Million | 304.76 Million | 208.76 Million | 220.22 Million | 225.41 Million |
| Operating Income | -95 Million | -81.06 Million | -113.38 Million | -48.28 Million | 39.91 Million | -17.53 Million |
| Interest Expense | 2 Million | 500 Thousand | 368 Thousand | 292 Thousand | 1.12 Million | 10.67 Million |
| Income Tax Expense | -7 Million | 407 Thousand | -32 Thousand | -2.94 Million | 9.55 Million | 1 Million |
| Earnings before Tax | -67 Million | -35.77 Million | -83.88 Million | -106.99 Million | 38.78 Million | -24.63 Million |
| Net Income | -60 Million | -36.18 Million | -83.85 Million | -104.04 Million | 29.23 Million | -25.64 Million |
| Earnings Per Share Basic | -0.54 | -0.58 | -1.47 | -2.07 | 0.75 | -3.63 |
| Earnings Per Share Diluted | -0.54 | -0.58 | -1.47 | -2.07 | 0.74 | -3.59 |
| Weighted Average Shares Outstanding | 111.53 Million | 62.34 Million | 57.18 Million | 50.27 Million | 38.73 Million | 7.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 111.53 Million | 62.34 Million | 57.18 Million | 50.27 Million | 39.44 Million | 7.14 Million |
| Gross Margin | 0.29 | 0.35 | 0.13 | 0.38 | 0.51 | 0.44 |
| EBIT Margin | -0.13 | -0.15 | -0.54 | -0.63 | 0.25 | -0.04 |
| Profit Margin | -0.21 | -0.10 | -0.44 | -0.65 | 0.13 | -0.12 |
| EBITDA | -37 Million | -11.89 Million | -74.06 Million | -87.66 Million | 46.39 Million | -7.73 Million |
| Earnings Before Tax Margin | -0.33 | -0.23 | -0.59 | -0.30 | 0.17 | -0.08 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 67 Million | 65 Million | 290 Million | 91 Million | 73 Million | 69 Million |
| Cost of Revenue | 84 Million | 88 Million | 397 Million | 111 Million | 50 Million | 52 Million |
| Gross Profit | -17 Million | -23 Million | -107 Million | -20 Million | 23 Million | 17 Million |
| Operating Expenses | 51 Million | 53 Million | 180 Million | 52 Million | 52 Million | 46 Million |
| Selling, General and Administrative Expenses | - | 20 Million | - | 25 Million | 21 Million | 14 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 51 Million | - | 7 Million | - | - | - |
| Cost and Expenses | 84 Million | 88 Million | 397 Million | 111 Million | 102 Million | 98 Million |
| Operating Income | -17 Million | -23 Million | -107 Million | -20 Million | -29 Million | -28 Million |
| Interest Expense | - | 18 Million | 2 Million | 2 Million | 19 Million | 2 Million |
| Income Tax Expense | - | 1 Million | -7 Million | 7.95 Million | 1 Million | -7 Million |
| Earnings before Tax | -16 Million | -42 Million | -67 Million | 12 Million | -29 Million | -31 Million |
| Net Income | -16 Million | -43 Million | -60 Million | 12 Million | -30 Million | -24 Million |
| Earnings Per Share Basic | -0.14 | -0.39 | - | 0.11 | -0.44 | -0.35 |
| Earnings Per Share Diluted | -0.14 | -0.39 | - | 0.11 | -0.44 | -0.35 |
| Weighted Average Shares Outstanding | 111.53 Million | 111.53 Million | 111.53 Million | 111.53 Million | 67.81 Million | 67.81 Million |
| Weighted Average Shares Outstanding (Diluted) | 111.53 Million | 111.53 Million | 111.53 Million | 111.53 Million | 67.81 Million | 67.81 Million |
| Gross Margin | -0.25 | -0.35 | -0.37 | -0.22 | 0.32 | 0.25 |
| EBIT Margin | -0.16 | -0.25 | - | -0.13 | -0.30 | -0.32 |
| Profit Margin | -0.24 | -0.66 | -0.21 | 0.13 | -0.41 | -0.35 |
| EBITDA | -11 Million | -16 Million | - | -12 Million | -22 Million | -22 Million |
| Earnings Before Tax Margin | -0.25 | -0.35 | -0.37 | -0.22 | -0.40 | -0.41 |
0922
VLE
000908
BIOIF
ANRG
ZIMLAB